Oct 31, 2021
Montréal-based healthtech company Optina Diagnostics has raised $24 million CAD in its Series A round to support the FDA regulatory submission of its early-detection disease solution.
seen from Malaysia
seen from Czechia
seen from India
seen from United Kingdom
seen from China
seen from China
seen from Türkiye
seen from Spain
seen from Greece
seen from Canada
seen from Greece
seen from Saudi Arabia
seen from Australia
seen from Saudi Arabia
seen from Canada
seen from Switzerland
seen from Romania
seen from China
seen from Argentina
seen from China
Montréal-based healthtech company Optina Diagnostics has raised $24 million CAD in its Series A round to support the FDA regulatory submission of its early-detection disease solution.